School of Medicine
Showing 1-100 of 358 Results
-
Bruce T. Adornato
Adjunct Clinical Professor, Neurology & Neurological Sciences
BioDr. Adornato joined the Department of Neurology as Voluntary Clinical Faculty in 1978, (subsequently Adjunct Clinical Faculty) and has served as Director of the Neuromuscular Laboratory from 1978 until 1983, performing and interpreting nerve and muscle biopsies as well as serving as attending physician directing residents and medical students in the diagnosis and care of his private patients admitted to Stanford Hospital. Since 1986, he has been attending physician at the Palo Alto VA Hospital, directing Stanford Neurology residents and medical students in the care of veterans. He has published 69 peer reviewed papers and a number of book chapters in the field of neurology. He is currently the medical officer of a silicon valley startup exploring mobility devices for the neurologically impaired.
-
Gregory W. Albers, MD
Coyote Foundation Professor and Professor, by courtesy, of Neurosurgery
Current Research and Scholarly InterestsOur group's research focus is the acute treatment and prevention of cerebrovascular disorders. Our primary interest is the use of advanced imaging techniques to expand the treatment window for ischemic stroke. We are also conducting clinical studies of both neuroprotective and thrombolytic strategies for the treatment of acute stroke and investigating new antithrombotic strategies for stroke prevention.
-
Katrin Andreasson
Professor of Neurology
Current Research and Scholarly InterestsOur research focuses on understanding how immune responses initiate and accelerate synaptic and neuronal injury in age-related neurodegeneration, including models of Alzheimer's disease and Parkinson's disease. We also focus on the role of immune responses in aggravating brain injury in models of stroke. Our goal is the identification of critical immune pathways that function in neurologic disorders and that can be targeted to elicit disease modifying effects.
-
Meredith Barad, MD
Clinical Associate Professor, Anesthesiology, Perioperative and Pain Medicine
Clinical Associate Professor, Neurology & Neurological SciencesCurrent Research and Scholarly InterestsMy current research interests involve novel treatment paradigms for challenging pain problems such as orofacial pain, trigeminal neuralgia and low pressure headaches. I am also interested in migraine and trigeminal autonomic cephalgias and their intersection with chronic pain.
-
Fiona Baumer
Assistant Professor of Neurology and of Pediatrics
Current Research and Scholarly InterestsCauses of Disturbed Cognition in Pediatric Epilepsy
-
Michael Eddy F Belloy
Postdoctoral Scholar, Neurology and Neurological Sciences
BioMy broad scientific goal is to investigate neurological disorders with the aim of identifying novel mechanisms that improve understanding of disease pathophysiology and that could lead to novel drug development. I pursue this goal by investigating the genetic risk factors of the respective disease under question, studying how they contribute to disruptions of brain function measured by in vivo imaging techniques, and how they correlate with the presentation of disease-sensitive biomarkers. Within this broader scope, my primary interest is to focus specifically on Alzheimer's disease, elucidating the genetic, molecular, and clinical spectrum of the disease, and hopefully, eventually, contributing to the path towards a cure.
I am a highly interdisciplinary scientist with experience in programming (using various scripting languages), advanced data analyses methods, neuroimaging, and studies of preclinical mouse models of Alzheimer’s disease. I also have a long-standing interest in brain function and network dynamics in both health and disease. More recently, I have further gained experience into the clinical aspects, imaging approaches, and genetics of Alzheimer’s disease. Altogether, this translates into my current research strategy in which I investigate large-scale multimodal datasets that contain information on genetics, clinical outcome measures, structural and functional brain properties, and other biomarker data.
I am currently a third-year post-doc at Stanford university, under the lead of Dr. Michael D Greicius. My main aims in this lab are to identify genetic factors that may be causative to Alzheimer's disease. Specifically, I aim to uncover genetic risk factors that interact with the Apolipoprotein E (APOE) gene to alter risk for Alzheimer’s disease. Further, I seek to identify how these genetic interactions with APOE differ by sex, age, and ethnicity. I believe this will allow the identification of novel genes relevant to Alzheimer's disease and contribute to advancing personalized genetic medicine.
During my PhD, supervised by Dr. Marleen Verhoye, Dr. Shella Keilholz and Dr. Georgios A Keliris, I worked on developing dynamic resting state functional (rsf)MRI in mice, which lead to the first observation of mouse Quasi-Periodic patterns, and related applications for Alzheimer's disease research in rodents. I still have an ongoing interest in dynamic rsfMRI research. -
Eran Blacher
Postdoctoral Scholar, Neurology and Neurological Sciences
BioDr. Blacher carried out his B.Sc studies in Life Sciences (2007-2010) and proceeded to Ph.D. in Neuroimmunology (2010-2015) under the Dean’s list honors direct Ph.D. program for outstanding students of Tel-Aviv University, Israel. His postdoctoral studies were carried out at the lab of Prof. Eran Elinav from the Immunology department at the Weizmann Institute of Science, Israel (2015-2018), where he studied the role of the Microbiome-gut-brain axis in the context of neurodegenerative diseases.
-
Helen Bronte-Stewart, MD, MS
John E. Cahill Family Professor, Professor of Neurology and, by courtesy, of Neurosurgery
Current Research and Scholarly InterestsMy research focus is human motor control and brain pathophysiology in movement disorders. Our overall goal is to understand the role of the basal ganglia electrical activity in the pathogenesis of movement disorders. We have developed novel computerized technology to measure fine, limb and postural movement. With these we are measuring local field potentials in basal ganglia nuclei in patients with Parkinson's disease and dystonian and correlating brain signalling with motor behavior.
-
Axel Brunger
Professor of Molecular and Cellular Physiology, of Neurology, of Photon Science and, by courtesy, of Structural Biology
Current Research and Scholarly InterestsOne of Axel Brunger's major goals is to decipher the molecular mechanisms of synaptic neurotransmitter release by conducting imaging and single-molecule/particle reconstitution experiments, combined with near-atomic resolution structural studies of the synaptic vesicle fusion machinery.
-
Paul Buckmaster, DVM, PhD
Professor of Comparative Medicine and of Neurology
Current Research and Scholarly InterestsMechanisms of epilepsy, especially temporal lobe epilepsy.
-
Marion S. Buckwalter, MD, PhD
Professor of Neurology and of Neurosurgery
Current Research and Scholarly InterestsThe goal of the Buckwalter Lab is to improve how people recover after a stroke. We use basic research to understand the cells, proteins, and genes that lead to successful recovery of function, and also how complications develop that impact quality of life after stroke. Ongoing projects are focused on understanding how inflammatory responses are regulated after a stroke and how to make recovery faster and better after stroke.
-
Marian (Mimi) Callanan
Affiliate, Neurology
BioMs. Callanan has many years experience as a Clinical Nurse Specialist in Epilepsy. She has been in this role at Stanford since the Center opened in 1990. She received her undergraduate degree at St Louis University and her graduate degree at the University of Pennsylvania. She is a past member of the Professional Advisory Board of the Epilepsy Foundation of America. She is a past President of the Epilepsy Society of San Francisco and was on the Board of Directors of the Epilepsy Foundation of Northern California. She is author of several publications pertaining to education of patients and families about epilepsy, and to the impact of epilepsy on life.
-
Steven D. Chang, MD
Robert C. and Jeannette Powell Neurosciences Professor and, by courtesy, of Otolaryngology - Head & Neck Surgery (OHNS) and of Neurology
Current Research and Scholarly InterestsClinical research includes studies in the treatment of cerebrovascular disorders, such as aneurysms and AVMs, as well as the use of radiosurgery to treat tumors and vascular malformations of the brain and spine.
Dr. Chang is C0-Director of the Cyberknife Radiosurgery Program.
Dr. Chang is also the head of the The Stanford Neuromolecular Innovation Program with the goal of developing new technologies to improve the diagnosis and treatment of patients affected by neurological conditions. -
S. Charles Cho, MD
Clinical Professor, Neurology & Neurological Sciences
Current Research and Scholarly InterestsClinical research focused on peripheral nerve and muscle disorders. Also involved with prevention of cerebrovascular disesase in the intraoperative setting. Ongoing clincial studies include treatments for Amyotrophic Lateral Sclerosis (ALS), Inflammatory Demyelinating Neuropathy and HIV neuropathic pain.
-
Mingyu Chung
Postdoctoral Scholar, Neurology and Neurological Sciences
Current Research and Scholarly InterestsRegulation of cell cycle and quiescence in tissue regeneration, homeostasis, and aging.
-
Robert Cowan, MD, FAAN
Clinical Professor, Neurology & Neurological Sciences
Clinical Professor (By courtesy), Anesthesiology, Perioperative and Pain MedicineCurrent Research and Scholarly InterestsCurrent interest focus on patient education technology and patient/physician communication with a particular emphasis on tools which increase encounter efficiency and improve outcomes. Basic research focuses on mechanisms of action in Chronic Daily Headache, with a particular emphasis on New Daily Persistent Headache. Techniques include fMRI, biomarker investigation and evoked potentials. Clinical research includes clinical trials of novel treatments for episodic and chronic headache forms.
-
John W. Day, MD, PhD
Professor of Neurology, of Pediatrics (Genetics) and, by courtesy, of Pathology
Current Research and Scholarly InterestsOur Neuromuscular Division coordinates a comprehensive effort to conquer peripheral nerve and muscle disorders, including the muscular dystrophies, motor neuron disorders, neuromuscular junction abnormalities, and peripheral neuropathies. With patients and families foremost in mind, we have had success defining and combating these diseases, with research focused on identifying genetic causes, developing novel treatment, and maximizing patient function by optimizing current management.
-
Gayle Deutsch, PhD, ABPP
Clinical Professor (Affiliated) [Shc], Neurology
Current Role at StanfordClinical Professor (Affiliated) Stanford Department of Neurology and Neurological Sciences
-
Jun Ding
Associate Professor of Neurosurgery and of Neurology
Current Research and Scholarly InterestsNeural circuits of movement control in health and movement disorders
-
Les Dorfman, MD
Professor of Neurology and Neurological Sciences, Emeritus
Current Research and Scholarly InterestsClinical electrophysiology of the peripheral and central nervous systems, including nerve conduction velocity; electromyography (EMG); and visual, auditory and somatosensory evoked potentials. Multiple sclerosis (MS) diagnosis and treatment. Neurological education.
-
Lauren Drag, PhD
Clinical Assistant Professor (Affiliated) [Shc], Neurology
BioLauren Drag, PhD, is a Clinical Assistant Professor(Affiliated) in the Department of Neurology and Neurological Sciences at Stanford University School of Medicine. She received her bachelor’s degree from Pomona College and a PhD in clinical psychology from the University of Arizona. Dr. Drag is board certified in Clinical Neuropsychology by the American Board of Professional Psychology.
She completed a clinical internship in neuropsychology at the VA Ann Arbor Medical Center and a two-year post-doctoral fellowship in neuropsychology at the University of Michigan Healthcare System. Prior to coming to Stanford, she was a researcher at the VA Palo Alto Medical Center and served as Director of the Neuropsychology Area of Emphasis at Palo Alto University. Dr. Drag’s research interests are in cognitive aging and traumatic brain injury. -
Dawn Duane
Clinical Associate Professor, Neurology & Neurological Sciences
Clinical Associate Professor, Pediatrics - OperationsCurrent Research and Scholarly InterestsI am a general pediatric neurologist. My interest is in clinical diagnosis and treatment of common neurologic diseases in pediatric patients and teaching feature doctors, neurologists and pediatric neurologists about pediatric neurology.
-
Shefali Dujari, MD
Clinical Assistant Professor, Neurology & Neurological Sciences
BioDr. Dujari is a neurologist who practices at Stanford Health Care – ValleyCare in Pleasanton. She is also a clinical assistant professor in the Department of Neurology at Stanford University School of Medicine.
She is dedicated to continuously improving the quality of patient care. She places special emphasis on enhancing patient-doctor communication.
She has made presentations to Stanford University School of Medicine on the treatment of bacterial meningitis and the management of thunderclap headaches in the emergency department. Posters co-developed by Dr. Dujari on quality improvement and patient safety advances have been presented at the Neurohospitalist Society Meeting and American Academy of Neurology Annual Meeting.
Dr. Dujari has earned honors from Stanford University School of Medicine, Boston University School of Medicine, and University of California, Davis. She also received the American Academy of Neurology Annual Meeting resident scholarship.
She is a member of the American Academy of Neurology and Alpha Omega Alpha Medical Honor Society. She is also a member of the Stanford Hospital Neurology Quality Council.
Dr. Dujari has led teams including the Resident Safety Council of Stanford Hospital, which designs and implements improvements in the patient healthcare experience, with a focus on improving communication about medication side effects. She led the wellness initiative of the Stanford Neurology Wellness and Mentoring Program to reduce resident burnout and increase peer-to-peer mentorship.
In addition, she co-founded Dance for Health at Boston University School of Medicine, which taught dance classes at assisted living and senior centers to improve motor coordination and create a social outlet for the elderly. -
Jeffrey Dunn, MD
Clinical Professor, Neurology & Neurological Sciences
Current Research and Scholarly InterestsTranslational research in the human application of emerging immunotherapies for neurological disease, focusing on Multiple Sclerosis, CIS, transverse myelitis and Neuromyelitis Optica (NMO). Collaborative research with Stanford and extramural scientific faculty to identify biomarkers of disease activity and treatment response in humans. Clinical trials to assess efficacy of emerging treatments for MS, CIS and NMO.
-
Emmanuel During, MD
Clinical Associate Professor, Psychiatry and Behavioral Sciences - Stanford Center for Sleep Sciences and Medicine
Clinical Associate Professor, Neurology & Neurological SciencesCurrent Research and Scholarly InterestsImproving diagnostics and therapeutics in RBD, using home ambulatory devices including wearable actigraphy, dry-EEG, to power clinical trials based on objective outcomes of RBD activity.
Controlling symptoms of RBD testing drugs rigorously.
Predicting the course of neurodegeneration using deep phenotyping using clinical and serum biomarkers, measures of autonomic impairment, skin biopsy, microbiome -
Alex N. Eischeid, MD
Clinical Assistant Professor, Neurology & Neurological Sciences
Clinical Assistant Professor, Neurology & Neurological SciencesBioDr. Eischeid is a board-certified neurologist and a clinical assistant professor in the Department of Neurology, Division of Movement Disorders at Stanford University School of Medicine. He specializes in the management of a wide range of neurological conditions. His focus is on movement disorders, including Parkinson’s disease, atypical parkinsonism, Huntington’s disease, ataxia, dystonia, and tremor. He has advanced training in botulinum toxin injections for dystonia and spasticity. Dr. Eischeid also delivers expertise in deep brain stimulation programming. With each patient, his goal is to safely and effectively relieve symptoms while improving quality of life.
Dr. Eischeid has been a presenter at the Stanford Alzheimer’s Disease Research Center Neuropathology Case Conference. He also has participated in meetings of the Movement Disorders Society and American Academy of Neurology.
Scholarship activities of Dr. Eischeid include writing peer-reviewed articles on topics such as the intracellular signaling that enables microglia to increase neurogenesis. His work has appeared in BMC Neuroscience, the Journal of Immunology, PLoS One, and elsewhere.
Among his honors, Dr. Eischeid received the Resident Fincham Award, given to a graduating neurology resident who best exemplifies the qualities of dedicated patient care and the highest level of collegiality. He was also named Administrative Chief Neurology Resident, an awarded position based on leadership qualities and academic performance. As a senior resident, he earned recognition as the “Best Resident On-Call.” Dr. Eischeid is a member of the American Academy of Neurology and Movement Disorders Society. He served on the Board of Directors of the Iowa Neurological Association. In his personal time, Dr. Eischeid has provided volunteer medical services at homeless shelters. -
Faisal Fecto
Instructor, Neurology & Neurological Sciences
BioDr. Fecto is a board-certified neurologist and neuromuscular medicine specialist. Dr. Fecto completed his medical training at the Aga Khan University in Pakistan in 2005, where he was also junior faculty till 2006. Dr. Fecto completed his PhD in neuroscience at Northwestern University in 2012 during which he was supported by a University Fellowship and an NIH/NIA Ruth L. Kirschstein National Research Service Award Predoctoral Fellowship. From 2012 to 2015 he completed his post-doctoral training in neurogenetics at Northwestern University as the Link Foundation Fellow. Dr. Fecto completed his neurology residency and chief residency at the University of Iowa Hospitals and Clinics as part of the clinical-neuroscientist and physician-scientist training programs. Dr. Fecto completed his fellowship in neuromuscular medicine at Stanford University in 2020.
Dr. Fecto has received several awards including the resident teaching award, resident team leader award, a resident lectureship by the Iowa Neurological Association, and a fellow scholarship by the American Academy of Neurology. Dr. Fecto is a well-published researcher and serves as an associate editor for the journal BMC Neurology. His research explores the pathogenic mechanisms that contribute to neuromuscular disorders such as amyotrophic lateral sclerosis and myotonic dystrophy. His research is supported by an NIH/NINDS R25 Research Education Grant. Dr. Fecto is a member of Alpha Omega Alpha Honor Medical Society, Sigma Xi Scientific Research Honor Society, American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, Society for Neuroscience, American Association for the Advancement of Science, and the American Medical Association. -
Anna Finley Caulfield, MD
Clinical Associate Professor, Neurology & Neurological Sciences
Current Research and Scholarly InterestsDr. Finley joined the Stanford Stroke Center in 2004 from Beth Israel Deaconess Medical Center in Boston. She cares for acute stroke patients and other neurologically critical ill patients in the intensive care unit. Currently, her research interests include hypothermia after cardiac arrest and comparing health care provider's predications of future neurological function in neurologically critical ill patients to their 6-month outcome.
-
Paul Graham Fisher, MD
Beirne Family Professor of Pediatric Neuro-Oncology, Professor of Pediatrics and, by courtesy, of Neurosurgery and of Epidemiology and Population Health
Current Research and Scholarly InterestsClinical neuro-oncology: My research explores the epidemiology, natural history, and disease patterns of brain tumors in childhood, as well as prospective clinical trials for treating these neoplasms. Research interests also include neurologic effects of cancer and its therapies, and childhood headaches.
-
Robert Fisher, MD, PhD
The Maslah Saul, MD, Professor and Professor, by courtesy, of Neurosurgery
Current Research and Scholarly InterestsDr. Fisher is interested in clincal, laboratory and translational aspects of epilepsy research. Prior work has included: electrical deep brain stimulation for epilepsy, studied in laboratory models and clinical trials; drug delivery to a seizure focus; mechanisms of absence epilepsy studied with in vitro slices of brain thalamus; hyperthermic seizures; diagnosis and treatment of non-epileptic seizures, the post-ictal state; driving and epilepsy; new antiepileptic drugs; surgery for epilepsy.
-
Nicole Francisco
Human Resources Administrator 1, Neurology
BioPronouns: she/her/hers
-
Paul George, MD, PhD
Assistant Professor of Neurology and, by courtesy, of Neurosurgery
On Partial Leave from 10/01/2021 To 04/30/2022Current Research and Scholarly InterestsCONDUCTIVE POLYMER SCAFFOLDS FOR STEM CELL-ENHANCED STROKE RECOVERY:
We focus on developing conductive polymers for stem cell applications. We have created a microfabricated, polymeric system that can continuously interact with its biological environment. This interactive polymer platform allows modifications of the recovery environment to determine essential repair mechanisms. Recent work studies the effect of electrical stimulation on neural stem cells seeded on the conductive scaffold and the pathways by which it enhances stroke recovery Further understanding the combined effect of electrical stimulation and stem cells in augmenting neural repair for clinical translational is a major focus of this research going forward.
BIOPOLYMER SYSTEMS FOR NEURAL RECOVERY AND STEM CELL MODULATION:
The George lab develops biomaterials to improve neural recovery in the peripheral and central nervous systems. By controlled release of drugs and molecules through biomaterials we can study the temporal effect of these neurotrophic factors on neural recovery and engineer drug delivery systems to enhance regenerative effects. By identifying the critical mechanisms for stroke and neural recovery, we are able to develop polymeric technologies for clinical translation in nerve regeneration and stroke recovery. Recent work utilizing these novel conductive polymers to differentiate stem cells for therapeutic and drug discovery applications.
APPLYING ENGINEERING TECHNIQUES TO DETERMINE BIOMARKERS FOR STROKE DIAGNOSTICS:
The ability to create diagnostic assays and techniques enables us to understand biological systems more completely and improve clinical management. Previous work utilized mass spectroscopy proteomics to find a simple serum biomarker for TIAs (a warning sign of stroke). Our study discovered a novel candidate marker, platelet basic protein. Current studies are underway to identify further candidate biomarkers using transcriptome analysis. More accurate diagnosis will allow for aggressive therapies to prevent subsequent strokes. -
Carl Gold
Clinical Assistant Professor, Neurology & Neurological Sciences
Clinical Assistant Professor (By courtesy), NeurosurgeryBioDr. Gold is a board-certified general neurologist who is fellowship-trained in the diagnosis and treatment of neurological disorders in hospitalized patients. He cares for a broad range of patients, including individuals with seizures, central nervous system infections, autoimmune diseases, headaches, neuromuscular conditions, and neurological complications of cancer. Dr. Gold has a particular clinical interest in the inpatient diagnosis of uncommon or rare neurological disorders. He directs quality improvement for the department of Neurology and is actively involved in projects to improve the experience of patients with neurological conditions at Stanford. His primary research interest focuses on enhancing the communication skills of neurology residents and he serves as the Director of the Stanford Neurology Residency Communication Coaching Program. He is also the Fellowship Director of the Stanford Neurohospitalist Fellowship.
For more information on the Stanford Neurohospitalist Program & Fellowship, please visit: https://med.stanford.edu/neurology/divisions/neurohospitalist.html
Additional information on Stanford Neurology's efforts in Quality, Safety, & Value can be found here: http://med.stanford.edu/neurology/quality.html
Learn more about the Stanford Neurology Communication Coaching Program by visiting: http://med.stanford.edu/neurology/education/resident-coaching.html -
Olga Fedin Goldberg
Clinical Associate Professor, Neurology & Neurological Sciences
BioDr. Goldberg is board-certified in Neurology by the American Board of Psychiatry and Neurology. She provides comprehensive neurologic care to patients with a broad range of neurologic conditions, including those who have multiple neurologic conditions. She is interested in medical education for neurology residents and for referring primary care providers and serves as Director of Neurology Resident Continuity Clinic. Additionally, she completed the Stanford CELT (Clinical Education Leadership Training) Program for developing skills in quality improvement. She has led or played a key role in multiple quality improvement projects in the Department of Neurology, including those focused on increasing patient understanding of their neurologic medications upon hospital discharge, improvement of outcomes for headache patients seen in primary care, and in optimizing clinic processes involved in collection of cerebrospinal fluid.
-
Neelam Goyal, MD
Clinical Associate Professor, Neurology & Neurological Sciences
Current Research and Scholarly InterestsDr. Goyal specializes in the diagnosis, management, and electrophysiological testing of neuromuscular disorder (including SFEMG), with expertise in immune-mediated disorders (myositis, myasthenia gravis, CIDP, and vasculitis) and ALS. Her research interest include monitoring and managing toxicity of immunosuppressive agents. She is co-director of the MDA clinic, and provides botulinum toxin for treatment of sialorrhea for ALS patients.
-
Gerald Grant, MD, FACS
Botha Chan Endowed Professor and Professor, by courtesy, of Neurology
Current Research and Scholarly InterestsDr. Grant directs a Blood-brain Barrier Translational Laboratory focusing on enhancing drug delivery to brain tumors in children.
-
Maxwell Greene, MD
Clinical Assistant Professor, Neurology & Neurological Sciences
BioDr. Greene is a board-certified, fellowship-trained neurologist. He is also a Clinical Assistant Professor of Neurology at Stanford University School of Medicine.
Dr. Greene provides clinical care for adult patients with disorders of the muscles and peripheral nerves that cause weakness and numbness. He specializes in diagnosing and treating neuromuscular diseases that include amyotrophic lateral sclerosis (ALS), all types of muscular dystrophy, chronic inflammatory demyelinating polyneuropathy (CIDP), myasthenia gravis, and Charcot-Marie-Tooth (CMT). For CIDP and CMT, Stanford is one of the few centers of excellence in the country.
A significant part of Dr. Greene’s practice involves investigational work, where he seeks to determine the cause of a patient’s symptoms. In addition to performing the full range of diagnostic tests including interpreting biopsy procedures, he has special qualifications in electrodiagnosis and the use of electromyography and nerve conduction studies.
Treatments offered by Dr. Greene cover the complete spectrum of options, with an emphasis on immune therapies for certain conditions. For CIDP and myasthenia gravis, he administers immune globulin, steroids, plasmapheresis, and rituximab. To help manage symptoms of CMT and support areas of the body weakened by this disease, he can recommend physical therapy, occupational therapy, and foot, ankle, and knee orthotics.
For the treatment of ALS and muscular dystrophy, Dr. Greene leads a multidisciplinary team offering physical and occupational therapy, pulmonary expertise, speech and swallow expertise, nutrition counseling, social services, and specialized nursing, and works together with genetic counseling. All team members collaborate closely to ensure patients receive the care and comfort needed to meet their emotional as well as physical needs.
As part of his commitment to advancing patients’ treatment options, Dr. Greene conducts clinical research. Among his current interests are
innovative new therapies for ALS and other nerve and muscular disorders. This is an exciting time in the field of neuromuscular medicine, with real potential for treatment breakthroughs for the first time in decades. Exploring these new directions enables Dr. Greene to offer Stanford patients access to options that may not be available anywhere else.
To highlight new advances for his peers, Dr. Greene has made national and regional presentations at conferences including the American Academy of Neurology meeting. Topics include the results of a study supported in part by the National Institutes of Health: paraneoplastic antibodies as markers of Hodgkin’s disease. JAMA Neurology published Dr. Greene’s article on this research.
Dr. Greene’s achievements have earned recognition from the American Academy of Neurology and other organizations. He is also the recipient of a travel award from the American Neurological Association and a grant from the NIH National Institute of Neurological Disorders and Stroke.
A member of the American Academy of Neurology, Dr. Greene is also an active member of the Western ALS Consortium and Northeastern ALS Consortium. -
Michael Greicius, MD, MPH
Iqbal Farrukh and Asad Jamal Professor and Professor, by courtesy, of Psychiatry and Behavioral Sciences (Administrative and Academic Special Programs)
Current Research and Scholarly InterestsAs the Medical Director of the Stanford Center for Memory Disorders and Principal Investigator of the Stanford Extreme Phenotypes in Alzheimer's Disease (StEP AD) Cohort, Dr. Greicius' research focuses on elucidating the neurobiologic underpinnings of AD. His lab combines cutting edge brain imaging, "deep" phenotyping, and whole-genome sequencing of human subjects to identify novel pathways involved in AD pathogenesis. The goal of his work is to develop effective treatment for AD patients.
-
Prashnna Gyawali
Postdoctoral Scholar, Neurology and Neurological Sciences
BioI am interested in exploring machine learning and deep learning methods for biomedical applications and medical imaging. Limited availability of labeled datasets to train machine learning models and large-scale variability in the datasets are some of the common challenges that I am interested in solving for the successful use of AI in this domain. Currently, I am exploring machine learning methods for genomics, where I am particularly focused on improving prediction for disease risk for Alzheimer’s disease for minority populations.
-
Jin S. Hahn, MD
Professor of Neurology at the Stanford University Medical Center, Emeritus
Current Research and Scholarly Interests1. Clinical informatics and electronic health records
2. Neonatal and fetal neurology
3. Prenatal diagnosis neurodevelopmental anomalies
4. Personalized Health and Wellness Records
